Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzuken Co's quarterly finished goods
increased
from Sep. 2025 (円146,691 Mil) to Dec. 2025 (円172,448 Mil) but then
declined
from Dec. 2025 (円172,448 Mil) to Mar. 2026 (円145,140 Mil).
Suzuken Co's annual finished goods
increased
from Mar. 2024 (円136,235 Mil) to Mar. 2025 (円146,668 Mil) but then
declined
from Mar. 2025 (円146,668 Mil) to Mar. 2026 (円145,140 Mil).
Suzuken Co Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Suzuken Co's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of 円145,140 Mil mean?
Suzuken Co (TSE:9987) has a Inventories, Finished Goods of 円145,140 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Suzuken Co and its competitors.
Is Suzuken Co's Inventories, Finished Goods too high?
Suzuken Co's current Inventories, Finished Goods is 円145,140 Mil. Overall, Suzuken Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Suzuken Co's Inventories, Finished Goods compare to MCK and CAH?
Suzuken Co's Inventories, Finished Goods of 円145,140 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Distribution company?
A good Inventories, Finished Goods depends on the Medical Distribution industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Suzuken Co and its competitors. Suzuken Co's current Inventories, Finished Goods is 円145,140 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzuken Co stock overvalued right now?
Based on GuruFocus' analysis, Suzuken Co (TSE:9987) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,922.27, compared to a current price of 円5,127.00 — trading 13.4% below its estimated fair value. The current Inventories, Finished Goods is 円145,140 Mil. Suzuken Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Suzuken Co (TSE:9987), the current Inventories, Finished Goods is 円145,140 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Suzuken Co (TSE:9987) Overvalued in 2026?
Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued.
The current stock price of 円5,127.00 is trading 13.4% below its estimated GF Value™ of 円5,922.27.
GuruFocus considers Suzuken Co to be Modestly Undervalued.
Key valuation signals for TSE:9987:
Inventories, Finished Goods: 円145,140 Mil
GF Value™: 円5,922.27 vs. price of 円5,127.00 (13.4% below fair value)
No single metric tells the full story. See the TSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.
79GF Score
Get the complete analysis for TSE:9987
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9987 has been successfully added to your 
